Introduction

1 Introduction


For many years, neural therapy according to Huneke was unjustly forced into an outsider’s role as a fringe method in medicine. Now, more than fifty years after its discovery, the recognition is at last growing among medical practitioners at universities and hospitals that the selective use of local anesthetics can greatly enrich and expand the conventional therapeutic armory, since physicians such as Adler, P Dosch, Gross, Harrer, Kibler, Schoeler, Siegen, and the Viennese team of Bergsmann, Fleischhacker, Hopfer, Kellner, Pischinger, Stacher, and others have shown by their work that the effects of neural therapy can be proved objectively.


For years, more than 50 % of all established practitioners in West Germany have been using neural therapy successfully in their day-to-day practice, for both diagnostic and therapeutic purposes.


In 1928, the brothers Ferdinand and Walter Huneke published a joint paper on ‘Unfamiliar remote effects of local anesthetics’ (Unbekannte Fernwirkungen der Lokalanästhesie). They reported the successful treatment of painful conditions in segmental areas and drew attention to the importance of injecting the correct site. They soon recognized that when procaine is injected, previously unknown reflex-like reactions are produced via Head’s zones. In addition to the purely intravenous injections with which they had begun, they discovered that paravenous and intramuscular injections could also be effective. For this type of treatment Kibler suggested the name of ‘segmental therapy with local anesthetics.’


Preparations, Material, and Dosages


image Skin Disinfection1


We still learn more from life
than from our teachers.

–E. von Bergmann


Let me season what follows with an anecdote from my personal experience, to make what I have to say more palatable. As we know, even medicine is subject to fashions. At the start of the sulfonamide era, many a disciple of Aesculapius hastened to prove in well-founded scientific treatises that Prontosil worked genuine miracle cures in almost any internal and medical surgical disorders. Only a handful of doctors remained objective and adopted a wait-and-see attitude. Then it was Prontosil, yesterday it was penicillin, today it is corticosteroids, and tomorrow something else will be hailed as the wonder drug. I have no objection to progress. But the enthusiasm with which medicine greets each little step forward, with excessive praise and exaggerated expectations, and then has to backtrack, does tend to become just a little embarrassing after a while.


As a young student I had the good fortune of being allowed to watch Kulenkampff at Zwickau during an operation. In the middle of it, the master pulled off his gloves, threw them on the floor and went with bare hands into the abdominal cavity, so that he might be better able to feel something or other in there. I was speechless with surprise and my aseptic conscience was appalled. “Anything the matter with you?” he growled at me, when I finally and audibly caught my breath again. My carefully phrased objection received the grumbling reply: “My young friend, remember that you can defecate (though he used a shorter and more profane term) into the abdominal cavity, you may spit into the thoracic cavity without fear of retribution, but you must not even peep into the knee joint!”


As he was suturing the incision, I asked him whether he did not want to pour 50 mL of Prontosil solution into the abdominal cavity, as I had seen done elsewhere. His laughing reply was, at that time, something of a heresy, but today it seems wise: “No, why should I want to cover damaged and injured tissue with red dye as well?”


This experience came to mind in 1951, when I was able for the first time to watch F. Huneke in his practice in Duesseldorf, trying to steal with my eyes as much as I could for my own practice. I experienced the same slight shock when I found that he never disinfected the patient’s skin before giving his numerous injections. His followers have adopted his approach. Millions of injections have shown that infections and injection abscesses hardly ever result. A survey produced only eight reports of infections in 35 000 000 injections. In some of these the cause lay in a therapy using corticosteroids or high-dosage regulation-blocking agents, which had substantially reduced the body’s defensive capabilities. In others we regard the resulting abscess as exacerbation of an old sealed-off infection and as a healing reaction.


How does this come about? Is this to be interpreted to suggest that aseptic procedures are to be declared superfluous? There is no question of that, and for the benefit of critics who are not well-disposed to neural therapy let me emphasize that our syringes and needles must, of course, be sterile. Our experience with procaine has simply taught us to regard infection, and toxic and allergic reactions, from a new viewpoint. We explain the fact that even after injections under the scalp and into the oral mucosa no infection occurs, first of all by suggesting that the chemical and mechanical irritation produced by disinfecting the skin is perfectly capable of stirring the bacteria from a state of rest and making them virulent.


And then, of course, we are injecting procaine. As long ago as 1906, Spiess noted that anesthesia suppresses any inflammation. We see danger not in the pathogenic agents but in the nerve irritation (depolarization) they cause. But we can reverse this with our anesthetic preparations, using them to stop bacterial and virus attack and proliferation, and thus preventing infection. If we infiltrate procaine around a fresh snakebite, the venom can no longer act on the organism. This is explained first by the fact that the anesthetic breaks the conductivity of the nerve fibers. Thus, the nerves can no longer conduct the irritative stimuli to the nerve centers. But further, procaine is also capable of recharging the cell membranes damaged by the irritation and of restoring their normal electrical potential. By this means, the production of toxic stimuli is blocked, which would otherwise cause the center to respond with panicky, excessive, and therefore dangerous reactions. In tetanus, rabies, poliomyelitis, and many other diseases, we need to imagine similar processes taking place, reminding us of the interference-field theory and of the possibility available to us of eliminating the pathogenic nerve irritation with procaine. The picture is rounded out if in this connection we remember that serum sickness can be stopped by anesthetizing the serum injection site (Muschaweck).


Far more important than all theory, however, is the fact that, whether we like it or not, that is the way it is. Obviously, no one can be prevented from continuing to carry out the traditional, ritual acts of ablution and of disinfecting the patient’s skin before injecting procaine. In certain circumstances, as, for example, before deep injections in the perineal region and near the anus, we also disinfect first. Similarly, for injections into the joints and the subarachnoid space and ventricles, the same sort of asepsis and antiseptic precautions must govern our actions as for major surgery! The same applies to seriously ill patients before parenteral treatment and to patients who are treated with high doses of corticosteroids. As has been stated, in return we need have no misgivings about being somewhat less punctilious in all other cases.


T. C. Dann, in an article published in the Lancet, took the view that the standard few seconds’ routine skin disinfection before an injection is totally useless. At best, no more than ~ 80 % of all bacteria are killed thereby. He and his colleagues had been giving injections for 6 years without prior disinfection, without ever finding any harmful side-effects result. They disinfected the skin only in above-mentioned exceptional cases. But in all such cases the skin is thoroughly cleansed for at least 2 (preferably 5) minutes with iodine, alcohol, or hexachlorophene. In 1978, Felig, in the Lancet, went so far as to describe the business of disinfecting the skin before injections as an “unnecessary ritual act.” In diabetics, where the risk of infection is substantially greater, 1700 injections were given without any prior disinfection of the skin around the injection site; not a single case of local or general infection resulted.


image Procaine (Novocaine), “King of Medicines”2


My hobby?
Impletol, of course!

–F. Huneke to a reporter


Novocaine is the registered trade name owned by Hoechst Pharmaceuticals for the p-amino-benzoyl diethyl-aminoethanol hydrochloride discovered in 1905 by Einhorn. Its generic name is procaine. In earlier German and Soviet literature we generally find the name of Novocaine used, while British and American authors refer to procaine, the French to scurocaine.


Procaine is thus an alcohol ester of p-aminobenzoic acid (PAB). It is hydrolytically broken down and thus detoxified via a serum enzyme, plasmacholinesterase, which occurs everywhere in the body tissues. This process takes from 20 to 40 minutes and produces two antihistamine components of interest: PAB and diethyl-aminoethanol. In the process of being broken down it is metabolized so thoroughly that only a small part (~ 30 %) of it needs to be detoxified in the liver and only 2 % is eliminated unchanged via the kidneys. For this reason alone it is to be preferred for therapeutic purposes to a large number of more recent neural-therapeutic products based on an amide structure, such as Xylocaine, Scandicaine, Hostacaine etc., which need to be almost completely detoxified in the liver! Liver disease can lead to a reduction of the serum cholinesterase, because of which procaine will be metabolized more slowly. Other products such as butazolidine, chloramphenicol, and sulfonamides can delay detoxification. At this point, reference should also be made to the very rare congenital cholinesterase deficiency, which renders the patient incapable of metabolizing procaine.


Apart from the neural-therapeutic action developed by the intact procaine molecule in pathologically changed tissue, there is also the effect of its breakdown products. PAB (vitamin HI) is regarded as one of the organism’s enzyme-building blocks. It acts as an intermediate stage in the formation of folic acid and of the citrovorum factor, which transmits the carbon-1 fragments in intermediate metabolism. PAB is probably also the main active agent against pathological sclerosing and hardening of the tissues. Diethyl-aminoethanol is a vasodilator substance that acts on the circulation and lowers blood pressure. Its spasmolytic effect on tonically constricted vessels and its influence on the neurovegetative state in sympathetic and parasympathetic irritation has been proved. In addition, a mildly stimulant effect on the central nervous system and psyche is also ascribed to it. It stimulates hair growth and sometimes restores youthful color to gray hair.


Procaine blocks cholinesterase, inhibits the formation of acetylcholine and the sensitivity to stimuli of the peripheral choline receptors. It suppresses histamine formation. As a β-receptor blocker it eliminates the physiological and pathological reactions caused by stress and sympathicomimetics. It lowers the level of catecholamines in the blood (epinephrine, norepinephrine, dopa-mine).


For procaine and the other anesthetics, several specific pharmacological effects have been proved, all of which are desirable from our point of view. According to these studies:


1. It acts to restore neurovegetative equilibrium, i. e., it can act either as a stimulant, increasing tonicity, or as a relaxant to reduce tonicity, depending on the patient’s initial state.


2. It acts to relieve pain. Here, in addition to its central and peripheral analgesic effect, there is also an anti-pyretic, anti-allergic, and spasmolytic element. As the pain disappears, the reactive inflammation also vanishes. By eliminating pain receptors the pain threshold is raised. When the injections are placed correctly, this effect lasts longer than the anesthetic effect, which indicates a decrease of pathogenic feedback. This suggests that the repolarization of the cell membrane during the anesthesia-hyperpolarization, with subsequent membrane stabilization, has a positive effect on the regulation mechanisms.


3. Its effect on the nervous system is made up of its ability to act simultaneously on the peripheral, the autonomic, and on the central nervous systems. It alters the functional state of the nervous system by reducing its lability, thus making it less sensitive to harmful stimuli. It is thus in a position to eliminate the state of shock of different origins and degrees of severity. If used correctly locally, it blocks pathogenic reflexes and reactivates the previously blocked neurovegetative system with its spontaneous healing capability.


4. It develops a therapeutic effect on all three components of the blood supply, i. e., the heart, the vascular system, and the blood. It has a regulating effect on the blood supply, is anti-allergic and a vasodilator, and reduces the permeability of the vascular walls:


a. Around the heart it inhibits the stimulus formation and conduction, and acts anti-arrhythmically. It has an oxygen-conserving effect on the heart muscle.


b. Microcirculation improves with the opening of arteriovenous anastomoses. Edema can drain and inflammations improve. In animal testing, edema was prevented when paws were treated with procaine before compressing them.


c. Animal testing proved the antihistamine effects of procaine, particularly by affecting the acute serum shock and suppression of the Shwartzman reaction. The stimulation of sensitive fibers causes histamine secretion, which stimulates more receptors. The antidromic reflex causes further histamine secretion. This lasts for a short while because the secretion is limited. Initially, sympathicus stimulation causes a spasm of the arterioles, which turns into pathological vasodilation with edema formation, vascular bleeding, intense pain with limited mobility, and muscle dysfunction. The sealing effect of procaine on the capillary walls begins quickly, reaches its peak after 1 hour, and lasts for up to 4 hours. In animal testing using procaine, the Bezold-Jarisch reflex of the induced collapse (loss of blood pressure, slowing down of pulse and respiration) can be prevented.


5. It also acts on the smooth musculature. So, for example, it sensitizes the uterus with regard to the hormone of the posterior lobe of the pituitary.


6. It has a substantial influence on the formation and secretion of hormones and enzymes.


7. It stimulates diuresis.


8. According to Uri, it also acts “directly on those parts of the brain which are associated with the transformation of stimuli into sensations.”

May 31, 2016 | Posted by in ANESTHESIA | Comments Off on Introduction

Full access? Get Clinical Tree

Get Clinical Tree app for offline access